Chengdu Bright Eye Hospital Co. Ltd. (SHE:301239) — Market Cap & Net Worth
Market Cap & Net Worth: Chengdu Bright Eye Hospital Co. Ltd. (301239)
Chengdu Bright Eye Hospital Co. Ltd. (SHE:301239) has a market capitalization of $684.62 Million (CN¥4.68 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #10771 globally and #2956 in its home market, demonstrating a -2.13% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chengdu Bright Eye Hospital Co. Ltd.'s stock price CN¥31.27 by its total outstanding shares 149619048 (149.62 Million). Also see 301239 total assets for a full breakdown of the balance sheet.
Chengdu Bright Eye Hospital Co. Ltd. Market Cap History: 2022 to 2026
Chengdu Bright Eye Hospital Co. Ltd.'s market capitalization history from 2022 to 2026. Data shows change from $1.53 Billion to $684.62 Million (-11.42% CAGR). Also see 301239 cash generation efficiency for how efficiently the company converts equity into cash flow.
Chengdu Bright Eye Hospital Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chengdu Bright Eye Hospital Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 301239 live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.26x
Chengdu Bright Eye Hospital Co. Ltd.'s market cap is 0.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.53 Billion | $1.73 Billion | $20.57 Million | 0.89x | 74.27x |
| 2023 | $1.86 Billion | $2.72 Billion | $267.91 Million | 0.69x | 6.95x |
| 2024 | $1.03 Billion | $2.68 Billion | -$101.86 Million | 0.38x | N/A |
| 2025 | $720.09 Million | $2.80 Billion | -$60.92 Million | 0.26x | N/A |
Competitor Companies of 301239 by Market Capitalization
Companies near Chengdu Bright Eye Hospital Co. Ltd. in the global market cap rankings as of September 19, 2026. Review Chengdu Bright Eye Hospital Co. Ltd. (301239) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Chengdu Bright Eye Hospital Co. Ltd. by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #291 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #916 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #995 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1233 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #291 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $427.71 |
| #916 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.92 |
| #995 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1233 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $261.99 |
Chengdu Bright Eye Hospital Co. Ltd. Historical Marketcap From 2022 to 2026
Between 2022 and today, Chengdu Bright Eye Hospital Co. Ltd.'s market cap moved from $1.53 Billion to $ 684.62 Million, with a yearly change of -11.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥684.62 Million | -4.93% |
| 2025 | CN¥720.09 Million | -29.87% |
| 2024 | CN¥1.03 Billion | -44.87% |
| 2023 | CN¥1.86 Billion | +21.93% |
| 2022 | CN¥1.53 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Chengdu Bright Eye Hospital Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $684.62 Million USD |
| MoneyControl | $684.62 Million USD |
| MarketWatch | $684.62 Million USD |
| marketcap.company | $684.62 Million USD |
| Reuters | $684.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Chengdu Bright Eye Hospital Co. Ltd.
Bright Eye Hospital Group Co., Ltd., together with its subsidiaries, operates ophthalmic medical institutions in China. The company offers ophthalmic diagnostic and treatment services, including refractive surgery, medical optometry and glasses fitting, cataract surgery, glaucoma treatment, strabismus and amblyopia, pediatric ophthalmology, fundus diseases treatment, oculoplastic surgery, lacrima… Read more